Telomir Pharmaceuticals, Inc. (TELO)
NASDAQ: TELO · IEX Real-Time Price · USD
3.880
-0.090 (-2.27%)
Jul 26, 2024, 4:30 PM EDT - Market closed
Telomir Pharmaceuticals Market Cap
Telomir Pharmaceuticals has a market cap or net worth of $114.89 million as of July 26, 2024.
Market Cap
114.89M
Enterprise Value
108.35M
1-Year Change
n/a
Ranking
Category
Stock Price
$3.88
Market Cap Chart
Since the IPO on February 9, 2024, Telomir Pharmaceuticals's market cap has decreased from $207.27M to $114.89M, a decrease of -44.57%. That is a compound annual growth rate of -72.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2024 | 117.60M | -43.26% |
| Feb 9, 2024 | 207.27M | - |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 122.84M |
| CervoMed | 122.57M |
| Relmada Therapeutics | 122.51M |
| BrainsWay | 121.34M |
| Adagene | 120.66M |
| Annovis Bio | 120.32M |
| Werewolf Therapeutics | 119.50M |
| Adicet Bio | 119.15M |